BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38376311)

  • 61. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.
    Cattani P; Zannoni GF; Ricci C; D'Onghia S; Trivellizzi IN; Di Franco A; Vellone VG; Durante M; Fadda G; Scambia G; Capelli G; De Vincenzo R
    J Clin Microbiol; 2009 Dec; 47(12):3895-901. PubMed ID: 19828739
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16
    Kawashita S; Matsuda K; Kondo H; Kitajima Y; Hasegawa Y; Shimada T; Kitajima M; Miura K; Nakashima M; Masuzaki H
    Cancer Control; 2020; 27(1):1073274819901170. PubMed ID: 32077330
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection.
    Cho YA; Chung JM; Ryu H; Kim EK; Cho BC; Yoon SO
    Cancer Res Treat; 2019 Jul; 51(3):1052-1063. PubMed ID: 30360033
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation.
    Nakao Y; Yang X; Yokoyama M; Ferenczy A; Tang SC; Pater MM; Pater A
    Br J Cancer; 1997; 75(10):1410-6. PubMed ID: 9166931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies.
    Cheah PL; Looi LM; Teoh KH; Mun KS; Nazarina AR
    Asian Pac J Cancer Prev; 2012; 13(2):469-72. PubMed ID: 22524808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody.
    Faoro V; Barbazza R; Bonin S; Brunetti D; Sulfaro S; Stanta G
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):341-50. PubMed ID: 22935825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis.
    Lea JS; Coleman R; Kurien A; Schorge JO; Miller DS; Minna JD; Muller CY
    Am J Obstet Gynecol; 2004 Mar; 190(3):674-9. PubMed ID: 15041998
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications.
    Zappacosta R; Colasante A; Viola P; D'Antuono T; Lattanzio G; Capanna S; Gatta DM; Rosini S
    Biomed Res Int; 2013; 2013():453606. PubMed ID: 24369532
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
    Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Relationship between human papillomavirus E7 protein and Rb gene product in fresh tissues of squamous cervical carcinoma].
    Wang P; Peng Z; Wang H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):722-4. PubMed ID: 9772434
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma.
    Ralli M; Singh S; Yadav SP; Sharma N; Verma R; Sen R
    J Cancer Res Ther; 2016; 12(1):232-7. PubMed ID: 27072243
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Uterine cervical squamous cell carcinoma without p16 (CDKN2A) expression: Heterogeneous causes of an unusual immunophenotype.
    Rokutan-Kurata M; Minamiguchi S; Kataoka TR; Abiko K; Mandai M; Haga H
    Pathol Int; 2020 Jul; 70(7):413-421. PubMed ID: 32304153
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic utility of p16 immunocytochemistry in metastatic cervical lymph nodes in head and neck cancers.
    Kapoor D; Handa U; Kundu R; Das A
    Diagn Cytopathol; 2021 Apr; 49(4):469-474. PubMed ID: 33428334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of MicroRNA-10b Expression and P16 with Pathological Features in Various Stages of Cervical Precancerous Lesions.
    Deng Y; Jiang H; Wu D
    Cell Mol Biol (Noisy-le-grand); 2023 Jan; 69(1):109-113. PubMed ID: 37213147
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
    Cai S; Han K
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
    [TBL] [Abstract][Full Text] [Related]  

  • 78. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
    Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
    Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of antibody to E2 protein of human papillomavirus and p16
    Chuerduangphui J; Pientong C; Swangphon P; Luanratanakorn S; Sangkomkamhang U; Tungsiriwattana T; Kleebkaow P; Burassakarn A; Ekalaksananan T
    Med Oncol; 2018 May; 35(6):93. PubMed ID: 29744680
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
    Balsitis S; Dick F; Dyson N; Lambert PF
    Cancer Res; 2006 Oct; 66(19):9393-400. PubMed ID: 17018593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.